Zobrazeno 1 - 10
of 80
pro vyhledávání: '"S. Chateau-Joubert"'
Autor:
F. Coussy, R. El Botty, M. Lavigne, C. Gu, L. Fuhrmann, A. Briaux, L. de Koning, A. Dahmani, E. Montaudon, L. Morisset, L. Huguet, L. Sourd, P. Painsec, S. Chateau-Joubert, T. Larcher, S. Vacher, S. Melaabi, A. Vincent Salomon, E. Marangoni, I. Bieche
Publikováno v:
Journal of Hematology & Oncology, Vol 13, Iss 1, Pp 1-10 (2020)
Abstract Background Metaplastic breast cancer (MBC) is a rare form of breast cancer characterized by an aggressive clinical presentation, with a poor response to standard chemotherapy. MBCs are typically triple-negative breast cancers (TNBCs), freque
Externí odkaz:
https://doaj.org/article/cbf006702ebb4d399142c2a6ff973310
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sabina Cosulich, Lila Zabaglo, Ricardo Ribas, Sunil Pancholi, Andrew Dodson, Eugene Schuster, Mitch Dowsett, Stephen R. D. Johnston, Qiong Gao, Mariana Ferreira Leal, Nikiana Simigdala, S. Chateau-Joubert, Lesley-Ann Martin, Elisabetta Maragoni, Margaret Hills
Publikováno v:
Breast Cancer Research, Vol 21, Iss 1, Pp 1-14 (2019)
Breast Cancer Research : BCR
Breast Cancer Research : BCR
Background Endocrine therapies are still the main strategy for the treatment of oestrogen receptor-positive (ER+) breast cancers (BC), but resistance remains problematic. Cross-talk between ER and PI3K/AKT/mTORC has been associated with ligand-indepe
Autor:
F. Coussy, R. Botty, M. Lavigne, C. Gu, L. Fuhrmann, A. Briaux, L. Koning, A. Dahmani, E. Montaudon, L. Morisset, L. Huguet, L. Sourd, P. Painsec, S. Chateau-Joubert, T. Larcher, S. Vacher, S. Melaabi, A. Salomon, E. Marangoni, I. Bieche
Additional file 1: Table S1. Characteristics of TNBC patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::029c18dec48ae9189c09c9280f977f53
Autor:
F. Coussy, R. Botty, M. Lavigne, C. Gu, L. Fuhrmann, A. Briaux, L. Koning, A. Dahmani, E. Montaudon, L. Morisset, L. Huguet, L. Sourd, P. Painsec, S. Chateau-Joubert, T. Larcher, S. Vacher, S. Melaabi, A. Salomon, E. Marangoni, I. Bieche
Additional file 2: Figure S1. Genomic and proteic analysis of PI3K-AKT-mTOR and RTK-MAPK pathways in PDX models.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35797ad5bb508e5f8f120baec2c9ef3a
Autor:
Ahmed Dahmani, Adrien Briaux, L. De Koning, Ivan Bièche, Samia Melaabi, C. Gu, Marion Lavigne, Elodie Montaudon, Sophie Vacher, R. El Botty, Léa Huguet, Laura Sourd, Ludivine Morisset, Pierre Painsec, Laetitia Fuhrmann, A. Vincent Salomon, Elisabetta Marangoni, S. Chateau-Joubert, Thibaut Larcher, Florence Coussy
Publikováno v:
Journal of Hematology and Oncology
Journal of Hematology and Oncology, BioMed Central, 2020, 13 (1), ⟨10.1186/s13045-020-0846-y⟩
Journal of Hematology and Oncology 1 (13), . (2020)
Journal of Hematology and Oncology, 2020, 13 (1), ⟨10.1186/s13045-020-0846-y⟩
Journal of Hematology & Oncology
Journal of Hematology & Oncology, Vol 13, Iss 1, Pp 1-10 (2020)
Journal of Hematology and Oncology, BioMed Central, 2020, 13 (1), ⟨10.1186/s13045-020-0846-y⟩
Journal of Hematology and Oncology 1 (13), . (2020)
Journal of Hematology and Oncology, 2020, 13 (1), ⟨10.1186/s13045-020-0846-y⟩
Journal of Hematology & Oncology
Journal of Hematology & Oncology, Vol 13, Iss 1, Pp 1-10 (2020)
Background Metaplastic breast cancer (MBC) is a rare form of breast cancer characterized by an aggressive clinical presentation, with a poor response to standard chemotherapy. MBCs are typically triple-negative breast cancers (TNBCs), frequently with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5eb82233a830089db4f9ce445fba42b
https://hal.archives-ouvertes.fr/hal-02508763
https://hal.archives-ouvertes.fr/hal-02508763
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
O. Abdel-Wahab, A. Akcakanat, S.E. Boyle, T. Brabb, C. Brayton, A. Bruna, D.M. Burgenske, J.W. Cassidy, S. Chateau-Joubert, W. Cheng, Y. Chen, L.A. Colby, E. Corwin, E. de Stanchina, O. Duchamp, J. Eswaraka, K.W. Evans, B. Fang, C.G. Fedele, J.B. Fleming, J.-J. Fontaine, A. Giddabasappa, E. Girard, L.R. Hill, D.K. Hirenallur-Shanthappa, G.Y. Ho, G. Inghirami, B.M. Iritani, Y. Jiang, S.D. Kaffenberger, A. Krivtsov, M.G. Lawrence, L. Liang, J. Liu, J.P. MacKeigan, E. Marangoni, M. Mattar, I. Mercado-Uribe, F. Meric-Bernstam, G.B. Mills, N. Niu, J.M. Olson, N. Paez-Arango, K. Paz, K. Pham, S.P.S. Pillai, M. Pizzi, J.T. Poirier, J.A. Ramírez, M.V. Rios Perez, G. Risbridger, P.J. Russell, P. Sathyan, M. Scaltriti, S.C. Schmechel, C. Scott, C.L. Scott, J.-L. Servely, M. Shackleton, B.W. Simons, J. Snyder, A.K. Sood, A.D. Strand, R. Taylor, S. Thompson-Iritani, P.T. Tinkey, R. Uthamanthil, L. Wang, E.D. Williams, E. Yuca, J. Zhang, R. Zhang
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3077c26722574fdf1ca460ec5178d45
https://doi.org/10.1016/b978-0-12-804010-2.01002-x
https://doi.org/10.1016/b978-0-12-804010-2.01002-x
Autor:
P de la Grange, K. Slimane, Aurélie Thuleau, Franck Assayag, S. Chateau-Joubert, David Gentien, Rania El-Botty, M Huerre, Elisabetta Marangoni, Ivan Bièche, PH Cottu, Rana Hatem, Sophie Richon
Publikováno v:
Cancer Research. 73:P5-09
Background: Acquired resistance to endocrine treatments (ET) occurs in more than 70% of cases of luminal breast cancer (LBC). We used patient derived xenografts (PDX) models of LBC to study molecular changes associated with acquired resistance to dif